Plant-Based Diet for Obesity
(SB Pilot Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to develop a tasty, plant-based diet to help Latino adults with obesity lose weight and improve health. The study will also create a lifestyle program, guided by community health workers, to help participants integrate this diet into their daily lives. Participants will be divided into two groups: one will follow the behavioral plant-based dietary intervention, while the other will receive standard care. Ideal candidates are Latino adults who are not diabetic and have a Body Mass Index (BMI) between 30 and 42, a measure of body fat based on height and weight. As an unphased trial, this study offers a unique opportunity to contribute to innovative dietary research and potentially enhance personal health.
Do I need to stop taking my current medications for the trial?
The trial does not specify if you need to stop taking your current medications, but it excludes those using medications that could affect the study's outcome. It's best to discuss your specific medications with the trial team.
What prior data suggests that this dietary intervention is safe for weight loss in the Latino population?
Research has shown that plant-based diets can be safe and beneficial for people with obesity. Studies have found that these diets aid in weight loss and improve heart health. Those who primarily consume plants tend to have lower rates of overweight and obesity compared to individuals who consume more meat and processed foods.
Early findings suggest that most people tolerate plant-based diets well. Research with Latino communities has focused on adapting these diets to cultural preferences, which helps individuals maintain them and experience health benefits. Many report positive changes, such as improved metabolism and reduced risk factors for diabetes, without serious side effects.
Overall, evidence suggests that plant-based diets are a safe choice for improving health, particularly for those dealing with obesity.12345Why are researchers excited about this trial?
Unlike traditional obesity treatments that often rely on medication or surgical intervention, the plant-based dietary intervention offers a natural and behavioral approach to weight management. Researchers are excited because this method focuses on a whole-food, plant-based diet, which is rich in nutrients and fiber, potentially leading to improved metabolic health and sustainable weight loss without the need for drugs. Moreover, this approach promotes long-term lifestyle changes by involving community health workers to support participants, making it a holistic alternative to conventional treatments.
What evidence suggests that this plant-based dietary intervention is effective for obesity?
Research has shown that plant-based diets can aid in weight loss. Individuals who consume more plant-based foods often maintain lower body weight and face a reduced risk of obesity compared to those who consume more meat and processed foods. A review of various studies found that plant-based diets, adapted to fit different cultures, increased fruit and vegetable intake, which also helped reduce obesity. One analysis found that vegan diets resulted in more weight loss than diets including dairy and eggs. In this trial, participants in the experimental arm will receive a behavioral plant-based dietary intervention, aiming to leverage these benefits to manage weight and improve health.56789
Who Is on the Research Team?
Miriam Jacome Sosa, PhD
Principal Investigator
Washington University School of Medicine
Are You a Good Fit for This Trial?
This trial is for Latino adults with obesity (BMI of 30-42 kg/m²) who do not have diabetes, severe health conditions, or recent significant weight changes. Participants should not be pregnant, breastfeeding, or using medications that affect the study's outcomes.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a 16-week behavioral plant-based dietary intervention delivered by community health workers
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Behavioral plant-based dietary intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Washington University School of Medicine
Lead Sponsor
Eli Lilly and Company
Industry Sponsor
Dr. Daniel Skovronsky
Eli Lilly and Company
Chief Medical Officer since 2018
MD from Harvard Medical School
David A. Ricks
Eli Lilly and Company
Chief Executive Officer since 2017
BSc from Purdue University, MBA from Indiana University
Sansum Diabetes Research Institute
Collaborator
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator